Literature DB >> 33508679

Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.

Munther Alomari1, Muhammad Taha2, Fazal Rahim3, Manikandan Selvaraj4, Naveed Iqbal5, Sridevi Chigurupati6, Shafqat Hussain7, Nizam Uddin8, Noor Barak Almandil9, Muhammad Nawaz10, Rai Khalid Farooq11, Khalid Mohammed Khan12.   

Abstract

A series of nineteen (1-19) indole-based-thiadiazole derivatives were synthesized, characterized by 1HNMR, 13C NMR, MS, and screened for α-glucosidase inhibition. All analogs showed varied α-glucosidase inhibitory potential with IC50 value ranged between 0.95 ± 0.05 to 13.60 ± 0.30 µM, when compared with the standard acarbose (IC50 = 1.70 ± 0.10). Analogs 17, 2, 1, 9, 7, 3, 15, 10, 16, and 14 with IC50 values 0.95 ± 0.05, 1.10 ± 0.10, 1.30 ± 0.10, 1.60 ± 0.10, 2.30 ± 0.10, 2.30 ± 0.10, 2.80 ± 0.10, 4.10 ± 0.20 and 4.80 ± 0.20 µM respectively showed highest α-glucosidase inhibition. All other analogs also exhibit excellent inhibitory potential. Structure activity relationships have been established for all compounds primarily based on substitution pattern on the phenyl ring. Through molecular docking study, binding interactions of the most active compounds were confirmed. We further studied the kinetics study of analogs 1, 2, 9 and 17 and found that they are Non-competitive inhibitors.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Indole-based-thiadiazole; Molecular docking; Structure activity relationship; Synthesis; α-Glucosidase inhibition

Year:  2021        PMID: 33508679     DOI: 10.1016/j.bioorg.2021.104638

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  1 in total

1.  Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.

Authors:  Aida Iraji; Diba Shareghi-Brojeni; Somayeh Mojtabavi; Mohammad Ali Faramarzi; Tahmineh Akbarzadeh; Mina Saeedi
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.